From: Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study
Cure
Group I
Group II
Test value*
p value
No. = 50
No. = 41
Complete
50 (100.0%)
39 (95.1%)
2.494
0.114
Relapse
0 (0.0%)
2 (4.9%)